Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CASH FLOWS

v3.21.4
CONDENSED STATEMENT OF CASH FLOWS - USD ($)
1 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (9,347) $ 5,409,084
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Income from investments held in Trust Account   (16,040)
Change in fair value of derivative warrant liabilities   (7,021,200)
Financing cost - derivative warrant liabilities   821,170
Changes in operating assets and liabilities:    
Prepaid expenses (653) (379,375)
Accounts payable   889
Accounts payable - related party   120,000
Accrued expenses   154,332
Net cash used in operating activities (10,000) (911,140)
Cash Flows from Investing Activities:    
Principal deposited in Trust Account   (414,000,000)
Net cash used in investing activities   (414,000,000)
Cash Flows from Financing Activities:    
Proceeds from note payable to related party 10,000  
Proceeds received from initial public offering, gross   414,000,000
Proceeds from private placement   10,280,000
Repayment of notes payable to related party   (185,116)
Offering costs paid   (8,715,098)
Net cash provided by financing activities 10,000.00 415,379,786
Net change in cash   468,646
Cash - beginning of the period   6,410
Cash - end of the period   475,056
Supplemental disclosure of noncash investing and financing activities:    
Deferred offering costs included in accrued expenses   85,000
Deferred offering costs included in accounts payable 116,374  
Deferred offering costs included in notes payable 107,350 45,167
Deferred underwriting commissions in connection with the initial public offering   $ 14,490,000
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares 17,000  
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares $ 8,000